About
Telmisartan/Amlodipine/Hydrochlorothiazide is a triple-combination medication indicated for the comprehensive management of essential hypertension, particularly in patients whose blood pressure is not adequately controlled with dual therapy. Telmisartan, an angiotensin II receptor blocker (ARB), blocks the AT1 receptor, leading to vasodilation and reduced aldosterone effects. Amlodipine, a dihydropyridine calcium channel blocker (CCB), relaxes vascular smooth muscle, further contributing to vasodilation. Hydrochlorothiazide (HCTZ), a thiazide diuretic, increases the excretion of sodium and water, reducing blood volume. These three agents work synergistically through distinct and complementary mechanisms to provide powerful and sustained blood pressure reduction. This combination is particularly useful for patients with severe or resistant hypertension, offering enhanced efficacy and improved cardiovascular outcomes by targeting multiple pathways involved in blood pressure regulation and fluid balance.
Uses
- Treatment of essential hypertension, especially severe or resistant cases.
- Blood pressure control in patients requiring multiple antihypertensive agents.
- Reduction of cardiovascular risk in hypertensive patients.
- Management of hypertension with co-existing fluid retention.
Directions For Use
Take this medication orally, usually once daily, with or without food, as directed by your healthcare provider.
Benefits
- Provides powerful and sustained blood pressure control.
- Combines three complementary mechanisms for enhanced efficacy.
- Reduces the risk of cardiovascular events in high-risk individuals.
- Offers convenience with a single tablet for multiple medications.
- Effective for patients with resistant hypertension.
- Helps manage fluid retention and swelling.
Side Effects
- Dizziness
- Headache
- Peripheral edema
- Fatigue
- Nausea
- Hypotension
- Hyperkalemia (less common with HCTZ)
- Hypokalemia (due to HCTZ)
- Dehydration
- Muscle cramps
- Increased uric acid levels
- Photosensitivity
- Rash
Safety Measures
- Alcohol - Alcohol can significantly enhance the hypotensive effects, increasing the risk of dizziness, lightheadedness, or fainting. Avoid excessive consumption.
- Pregnancy - Contraindicated during the second and third trimesters of pregnancy due to fetal toxicity from the ARB component. Consult a doctor immediately if pregnant.
- Breastfeeding - Not recommended during breastfeeding as all components can pass into breast milk and may pose risks to the infant. A doctor should assess the risk-benefit.
- Liver - Use with caution in patients with hepatic impairment, as all components are metabolized by the liver or can precipitate hepatic coma (HCTZ). Dosage adjustment may be necessary.
- Kidney - Contraindicated in anuria. Use with caution and monitor kidney function closely in patients with severe renal impairment or renal artery stenosis.
- Lung - Generally safe for use in patients with lung conditions, though caution is advised in patients with a history of allergy to sulfonamide-derived drugs (HCTZ).
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!